Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Hoffmann-La Roche |
---|---|
Information provided by: | Hoffmann-La Roche |
ClinicalTrials.gov Identifier: | NCT00709891 |
This study will provide data on the performance of the AMPLICOR HPV test and the LA HPV test for identifying histologically confirmed high-grade cervical disease. The baseline, cross-sectional phase will be conducted with approximately 45,000 women undergoing routine cervical cancer screening, of whom 7,400 will be selected to undergo colposcopy and biopsy/ECC at baseline. These subjects will include women with cytology that is 'not normal' and a selection of those with 'normal' cytology who will enter a follow-up phase and undergo cytological evaluation annually for 3 years. In this follow up phase, colposcopy, biopsy/ECC will be performed only in women with cervical cytology considered 'not normal' at any of the annual follow up visits.
Condition | Intervention |
---|---|
HPV |
Device: Amplicor HPV Test Device: LINEAR ARRAY High Risk HPV Genotyping Test |
Study Type: | Interventional |
Study Design: | Diagnostic, Randomized, Single Blind (Subject), Uncontrolled, Parallel Assignment |
Official Title: | Evaluation of the AMPLICOR HPV Test and the LINEAR ARRAY High Risk HPV Genotyping Test for the Detection of High-Grade Cervical Disease in Women Undergoing Routine Cervical Cancer Screening Using Cervical Samples Prepared With the COBAS X421 Instrument. |
Study Start Date: | May 2008 |
Estimated Study Completion Date: | October 2009 |
Arms | Assigned Interventions |
---|---|
1: Experimental | Device: Amplicor HPV Test Device: LINEAR ARRAY High Risk HPV Genotyping Test |
Ages Eligible for Study: | 21 Years and older |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contact: Please reference Study ID Number: RD000649 | +1-973-235-5000 | |
Contact: or | 800-526-6367 (FOR US ONLY) |
Study Director: | Clinical Trials | Hoffmann-La Roche |
Responsible Party: | Hoffmann-La Roche ( Clinical Trials ) |
Study ID Numbers: | RD000649, MWP_HPV_159 |
Study First Received: | June 30, 2008 |
Last Updated: | January 9, 2009 |
ClinicalTrials.gov Identifier: | NCT00709891 |
Health Authority: | United States: Institutional Review Board |